CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash Flows From Operating Activities:
Net (Loss)	$ (11,825,007)	$ (10,185,356)
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:
Depreciation and Amortization	259,084	395,990
Share Based Compensation - Non-employee	88,487
Share Based Compensation- Employees	4,301,585	5,222,723
Restricted Stock Retained in Satisfaction of Tax Liabilities	(2,287,231)
Loss on Disposal of Assets	3,634	258
Loss (gain) on Sale of Investments Available for Sale	368,519	(3,302)
(Gain) on Sale of Investments Available for Sale	504,994
Changes in Assets and Liabilities:
(Increase) Decrease in Accounts Receivable	343,993	(2,543,404)
(Increase) in Inventory	(2,532,397)	(3,137,896)
(Increase) in Other Assets	349,378	(54,132)
Increase (Decrease) in Accounts Payable	(1,988,717)	980,981
Increase (Decrease) in Other Liabilities	(489,857)	106,441
Increase (decrease) Deferred License Revenue	(996,240)	(963,372)
Increase (decrease) in deferred drug license revenue	(136,362)	3,886,365
Changes in Assets and Liabilities	(5,450,202)	(1,725,017)
Cash (Used In) Operating Activities	(12,253,900)	(6,294,704)
Cash Flows From Investing Activities:
Purchase of Investments Available for Sale	(27,262,362)	(9,259,648)
Sale of Investments Available for Sale	33,351,339	8,328,987
Purchase of Equipment	(401,055)	(229,287)
Proceeds from Sale of Assets	450	1,000
Cash Provided by (Used In) Investing Activities	5,688,372	(1,158,948)
Cash Flows From Financing Activities:
Proceeds from the Issuance of Common Shares and Purchase Warrants		77,250
Cash Provided By (Used In) Financing Activities	(2,287,231)	77,250
Effects of exchange rate changes	(140)
(Decrease) Increase In Cash	(8,852,899)	(7,376,402)
Cash At Beginning Of Period	17,180,594	31,198,182
Cash At End Of Period	$ 8,327,695	23,821,780
Supplemental Cash Flow Information:
Income Taxes Paid		$ 404,527